BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Deals

  Jazz Moves to Snap Up Cannabinoid Company, Bolster Neurology Pipeline

  Jazz Pharmaceuticals will beef up its neurology pipeline with a $7.2 billion buyout of GW Pharmaceuticals, the only company yet to score U.S. regulatory approval for a cannabis-derived product.

  February 3, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• Rift Valley Fever Testing Demand Impelled by Increasing R&D on Discovery of Effective Treatment, Opines Fact.MR

  Fact.MR, a global research & consulting firm, in their latest edition of the report, states that the Rift Valley Fever Testing market will foresee a moderate growth pace in 2021 & beyond.

  February 3, 2021

   · 

  4 min read
• Topical Wound Agents Market: Topical Gel Segment to Witness High Demand

  Topical wound agents are medical preparations used to treat dermatological injuries. Topical wound agents are primarily formulated into creams, emulsions, oils, sprays, and others.

  February 3, 2021

   · 

  10 min read
• Microbiology Testing Market | Know the Latest Trends that have the Potential to bring Expansive Market Growth

  The global market for microbiology testing is estimated to expand at a promising pace in the next few years owing to the massive rise in the awareness level among patients about the variety of rampant chronic diseases, respiratory infections, and inflammatory conditions.

  February 3, 2021

   · 

  5 min read
• Business

  Chi-Med to Announce 2020 Final Results

  Hutchison China MediTech Limited will be announcing its final results for the year ended December 31, 2020 on Thursday, March 4, 2021 at 12:00 noon Greenwich Mean Time / 8:00 pm Hong Kong Time / 7:00 am Eastern Standard Time.

  February 3, 2021

   · 

  1 min read
• Pharm Country

  Tiziana Life Sciences CEO Discusses COVID-19 Trial Data in Exclusive Interview

  Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announced an interview with Dr. Kunwar Shailubhai, CEO and CSO, is now available.

  February 3, 2021

   · 

  1 min read
• Deals

  Biophytis Announces the Launch of its Proposed Public Offering and Nasdaq Listing - Feb 03, 2021

  Biophytis announces its intention to offer and sell, subject to market and other conditions, up to 12.0 million ordinary shares represented by 1.2 million American Depositary Shares, with each ADS representing ten ordinary shares, in the United States.

  February 3, 2021

   · 

  9 min read
• Syngenta Crop Protection and Insilico Medicine to Harness Artificial Intelligence to Transform Sustainable Product Innovation

  Multi-year collaboration will use artificial intelligence (AI) and deep learning to accelerate the invention of new, more sustainable products and technologies for growers

  February 3, 2021

   · 

  6 min read
• Business

  GSK and CureVac to Develop Next Generation MRNA COVID-19 Vaccines

  Development to begin immediately targeting vaccine availability in 2022, subject to regulatory approval

  February 3, 2021

   · 

  8 min read
• Abingworth raises $465m for new life sciences fund Abingworth Bioventures 8

  Oversubscribed transatlantic fund to invest in US, UK and European life science companies developing innovative therapeutics with potential to significantly improve human health

  February 3, 2021

   · 

  4 min read